Generation of RORγt+ Antigen-Specific T Regulatory 17 Cells from Foxp3+ Precursors in Autoimmunity
Byung Seok Kim(The University of Texas MD Anderson Cancer Center), Chen Dong(East China University of Technology), Kenji Ichiyama(The University of Osaka), Nipun A. Mistry(The University of Texas MD Anderson Cancer Center), Xuexian O. Yang(University of New Mexico), Roza Nurieva(The University of Texas MD Anderson Cancer Center), Li Zhang(Fourth Hospital of Changsha), Xiang Chen(Hunan Academy of Traditional Chinese Medicine), Young‐Hee Lee(The University of Texas MD Anderson Cancer Center), Kentaro Tanaka(Institute for the Future), Wei Jin(Hebei University of Economics and Business), Huiping Lu(Tsinghua University), Seon Hee Chang(The University of Texas MD Anderson Cancer Center), Yi-Bing Zhang(Chinese Academy of Sciences), Yeonseok Chung(Seoul National University)
Cited by 129
Related Papers
Pyroptosis: mechanisms and diseases
|Signal Transduction and Targeted Therapy|2021|2.3k
Regulatory T Cells and Human Disease
|Annual Review of Immunology|2020|1.1k
1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
|Molecular and Cellular Biology|2011|456
Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*
|Journal of Biological Chemistry|2008|433
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338